{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T02:20:20Z","timestamp":1784859620505,"version":"3.55.0"},"reference-count":190,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Because of its high prevalence and poor long-term clinical treatment effect, liver disease is regarded as a major public health problem around the world. Among them, viral hepatitis, fatty liver, cirrhosis, non-alcoholic fatty liver disease (NAFLD), and autoimmune liver disease are common causes and inducements of liver injury, and play an important role in the occurrence and development of hepatocellular carcinoma (HCC). Tanshinone IIA (TsIIA) is a fat soluble polyphenol of Salvia miltiorrhiza that is extracted from Salvia miltiorrhiza. Because of its strong biological activity (anti-inflammatory, antioxidant), it is widely used in Asia to treat cardiovascular and liver diseases. In addition, TsIIA has shown significant anti-HCC activity in previous studies. It not only has significant anti proliferation and pro apoptotic properties. It can also play an anti-cancer role by mediating a variety of signal pathways, including phosphatidylinositol-3-kinase (PI3K)\/protein kinase B (Akt)\/rapamycin (mTOR), mitogen-activated protein kinase (MAPK), and nuclear factor kappa-B (NF-\u03baB). This review not only reviews the existing evidence and molecular mechanism of TsIIA\u2019s anti-HCC effect but also reviews the liver-protective effect of TsIIA and its impact on liver fibrosis, NAFLD, and other risk factors for liver cancer. In addition, we also conducted network pharmacological analysis on TsIIA and HCC to further screen and explore the possible targets of TsIIA against hepatocellular carcinoma. It is expected to provide a theoretical basis for the development of anti-HCC-related drugs based on TsIIA.<\/jats:p>","DOI":"10.3389\/fonc.2023.1071415","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T16:13:19Z","timestamp":1675181599000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug"],"prefix":"10.3389","volume":"13","author":[{"given":"Hu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengbo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2019.03.001","article-title":"Targeting the mTOR regulatory network in hepatocellular carcinoma: Are we making headway","volume":"1871","author":"Yu","year":"2019","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"109543","DOI":"10.1016\/j.biopha.2019.109543","article-title":"Alkaloids from traditional Chinese medicine against hepatocellular carcinoma","volume":"120","author":"Liu","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B4","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","article-title":"Epidemiology and management of hepatocellular carcinoma","volume":"156","author":"Kulik","year":"2019","journal-title":"Gastroenterology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatol (Baltimore Md.)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-019-05593-8","article-title":"Multidisciplinary approach to HCC management: How can this be done","volume":"64","author":"Gadsden","year":"2019","journal-title":"Digest Dis Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet (London England)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"188314","DOI":"10.1016\/j.bbcan.2019.188314","article-title":"Challenges in liver cancer and possible treatment approaches","volume":"1873","author":"Anwanwan","year":"2020","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2147\/BTT.S23907","article-title":"Hepatocellular carcinoma: natural history, current management, and emerging tools","volume":"6","author":"Tinkle","year":"2012","journal-title":"Biol: Targets Ther"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218165","article-title":"Recent updates of transarterial chemoembolilzation in hepatocellular carcinoma","volume":"21","author":"Chang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/kjm2.12401","article-title":"Evolution of systemic treatment for advanced hepatocellular carcinoma","volume":"37","author":"Wu","year":"2021","journal-title":"Kaohsiung J Med Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1080\/14656566.2018.1479398","article-title":"Oral chemotherapy for the treatment of hepatocellular carcinoma","volume":"19","author":"Yamamoto","year":"2018","journal-title":"Expert Opin pharmacother"},{"key":"B13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/molecules21010051","article-title":"Chemical analysis of the herbal medicine salviae miltiorrhizae radix et rhizoma (Danshen)","volume":"21","author":"Pang","year":"2016","journal-title":"Molecules"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00202","article-title":"Tanshinones, critical pharmacological components in salvia miltiorrhiza","volume":"10","author":"Jiang","year":"2019","journal-title":"Front Pharmacol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymben.2011.02.003","article-title":"Metabolic engineering tanshinone biosynthetic pathway in salvia miltiorrhiza hairy root cultures","volume":"13","author":"Kai","year":"2011","journal-title":"Metab Eng"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2018.00554","article-title":"Transcription factor SmWRKY1 positively promotes the biosynthesis of tanshinones in salvia miltiorrhiza","volume":"9","author":"Cao","year":"2018","journal-title":"Front Plant Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2174\/0929867327666200521124850","article-title":"Tanshinones: An update in the medicinal chemistry in recent 5 years","volume":"28","author":"Lai","year":"2021","journal-title":"Curr Med Chem"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.611087","article-title":"A review of its anticancer effects","volume":"11","author":"Fang","year":"2020","journal-title":"Front Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.phymed.2015.12.004","article-title":"Cryptotanshinone, a compound of salvia miltiorrhiza inhibits pre-adipocytes differentiation by regulation of adipogenesis-related genes expression via STAT3 signaling","volume":"23","author":"Rahman","year":"2016","journal-title":"Phytomedicine"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2016.11.046","article-title":"Tanshinone IIA induced cell death via miR30b-p53-PTPN11\/SHP2 signaling pathway in human hepatocellular carcinoma cells","volume":"796","author":"Ren","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v10.i14.2024","article-title":"Growth inhibition and apoptosis induction of tanshinone II-a on human hepatocellular carcinoma cells","volume":"10","author":"Yuan","year":"2004","journal-title":"World J Gastroenterol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/2211-5463.13089","article-title":"Cytochrome P450 2A6 is associated with macrophage polarization and is a potential biomarker for hepatocellular carcinoma","volume":"11","author":"Jiang","year":"2021","journal-title":"FEBS Open Bio"},{"key":"B23","doi-asserted-by":"publisher","first-page":"16065","DOI":"10.1038\/cddiscovery.2016.65","article-title":"Simultaneous induction of apoptosis and necroptosis by tanshinone IIA in human hepatocellular carcinoma HepG2 cells","volume":"2","author":"Lin","year":"2016","journal-title":"Cell Death Discovery"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1039\/C5BM00224A","article-title":"Glycyrrhetinic acid-decorated and reduction-sensitive micelles to enhance the bioavailability and anti-hepatocellular carcinoma efficacy of tanshinone IIA","volume":"4","author":"Chen","year":"2016","journal-title":"Biomater Sci"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1039\/c0mb00343c","article-title":"Nano-LC-MS\/MS based proteomics of hepatocellular carcinoma cells compared to Chang liver cells and tanshinone IIA induction","volume":"7","author":"Long","year":"2011","journal-title":"Mol Biosyst"},{"key":"B26","article-title":"Synergistic combinations of tanshinone IIA and trans-resveratrol toward cisplatin-comparable cytotoxicity in HepG2 human hepatocellular carcinoma cells","volume":"34","author":"Chang","year":"2014","journal-title":"Anticancer Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"6756763","DOI":"10.1155\/2021\/6756763","article-title":"PEI-PEG-Coated mesoporous silica nanoparticles enhance the antitumor activity of tanshinone IIA and serve as a gene transfer vector","volume":"2021","author":"Zhu","year":"2021","journal-title":"Evidence-Based complement Altern med.: eCAM"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20111322","article-title":"Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells","volume":"442","author":"Liu","year":"2012","journal-title":"Biochem J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000000144","article-title":"Novel mechanisms involving chemically modified tetracycline 3 cytotoxicity","volume":"25","author":"Zhao","year":"2014","journal-title":"Anti-cancer Drugs"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2014.09.017","article-title":"TPGS-g-PLGA\/Pluronic F68 mixed micelles for tanshinone IIA delivery in cancer therapy","volume":"476","author":"Zhang","year":"2014","journal-title":"Int J pharmaceutics"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1177\/030089160909500623","article-title":"Tanshinone II-a inhibits invasion and metastasis of human hepatocellular carcinoma cells in vitro and in vivo","volume":"95","author":"Yuxian","year":"2009","journal-title":"Tumori"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm_00000476","article-title":"Tanshinone IIA inhibits hep-J5 cells by increasing calreticulin, caspase 12 and GADD153 protein expression","volume":"26","author":"Cheng","year":"2010","journal-title":"Int J Mol Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1021\/np900792p","article-title":"Cytotoxic effects of tanshinones from salvia miltiorrhiza on doxorubicin-resistant human liver cancer cells","volume":"73","author":"Lee","year":"2010","journal-title":"J Natural prod."},{"key":"B34","article-title":"The Chinese medicine, jianpi huayu decoction, inhibits the epithelial mesenchymal transition via the regulation of the Smad3\/Smad7 cascade","volume":"9","author":"Zhong","year":"2017","journal-title":"Am J Trans Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1007\/s11418-011-0576-0","article-title":"Tanshinone IIA activates calcium-dependent apoptosis signaling pathway in human hepatoma cells","volume":"66","author":"Dai","year":"2012","journal-title":"J Natural Medicines"},{"key":"B36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ijpharm.2011.12.049","article-title":"Development of intravenous lipid emulsion of tanshinone IIA and evaluation of its anti-hepatoma activity in vitro","volume":"424","author":"Chu","year":"2012","journal-title":"Int J pharmaceutics"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3785\/j.issn.1008-9292.2009.02.008","article-title":"[Effect of tanshinone II a on expression of EGF and EGFR in hepatocellular carcinoma cell line SMMC-7721]","volume":"38","author":"Zhai","year":"2009","journal-title":"Zhejiang da xue xue bao Yi xue ban = J Zhejiang Univ Med Sci"},{"key":"B38","first-page":"99","article-title":"[Inhibition of cell growth and induction of apoptosis in human hepatoma cell line HepG2 by tanshione IIA]","volume":"32","author":"Zhong","year":"2007","journal-title":"Zhong nan da xue xue bao Yi xue ban = J Cent South Univ Med Sci"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1080\/10611860802374303","article-title":"Novel polymeric nanoparticles containing tanshinone IIA for the treatment of hepatoma","volume":"16","author":"Li","year":"2008","journal-title":"J Drug Targeting"},{"key":"B40","doi-asserted-by":"publisher","first-page":"6231751","DOI":"10.1155\/2020\/6231751","article-title":"The synergistic antitumor effect of tanshinone IIA plus adriamycin on human hepatocellular carcinoma xenograft in BALB\/C nude mice and their influences on cytochrome P450 CYP3A4 in vivo","volume":"2020","author":"Liu","year":"2020","journal-title":"Adv Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1756-8722-5-69","article-title":"Tanshinone IIA inhibits metastasis after palliative resection of hepatocellular carcinoma and prolongs survival in part via vascular normalization","volume":"5","author":"Wang","year":"2012","journal-title":"J Hematol Oncol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3892\/mmr.2012.1129","article-title":"Anticancer activities of tanshinone microemulsion against hepatocellular carcinoma in vitro and in vivo","volume":"7","author":"Ma","year":"2013","journal-title":"Mol Med Rep"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2011.631","article-title":"Tanshinone IIA inhibits human hepatocellular carcinoma J5 cell growth by increasing bax and caspase 3 and decreasing CD31 expression in vivo","volume":"5","author":"Chien","year":"2012","journal-title":"Mol Med Rep"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1166\/jbn.2014.1982","article-title":"Targeted delivery of tanshinone IIA-conjugated mPEG-PLGA-PLL-cRGD nanoparticles to hepatocellular carcinoma","volume":"10","author":"Wang","year":"2014","journal-title":"J Biomed nanotechnol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2015.07.047","article-title":"Inhibition of cytochrome P450 2J2 by tanshinone IIA induces apoptotic cell death in hepatocellular carcinoma HepG2 cells","volume":"764","author":"Jeon","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1142\/S0192415X13500146","article-title":"Novel microemulsion of tanshinone IIA, isolated from salvia miltiorrhiza bunge, exerts anticancer activity through inducing apoptosis in hepatoma cells","volume":"41","author":"Ma","year":"2013","journal-title":"Am J Chin Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/S1499-3872(17)60014-6","article-title":"Crosstalk of liver immune cells and cell death mechanisms in different murine models of liver injury and its clinical relevance","volume":"16","author":"Khan","year":"2017","journal-title":"Hepatob pancreatic Dis int: HBPD Int"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.04.033","article-title":"Danger signals in liver injury and restoration of homeostasis","volume":"73","author":"Han","year":"2020","journal-title":"J Hepatol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i25.8082","article-title":"Oxidative stress as a crucial factor in liver diseases","volume":"20","author":"Cicho\u017c-Lach","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-019-03667-9","article-title":"ROS and diseases: role in metabolism and energy supply","volume":"467","author":"Yang","year":"2020","journal-title":"Mol Cell Biochem"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3109\/10715762.2013.811721","article-title":"Current knowledge on oxidative stress in hepatic ischemia\/reperfusion","volume":"47","author":"Elias-Mir\u00f3","year":"2013","journal-title":"Free Radical Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1172\/JCI88881","article-title":"Liver inflammation and fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J Clin Invest"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27175594","article-title":"Molecular mechanism of tanshinone against prostate cancer","volume":"27","author":"Li","year":"2022","journal-title":"Molecules"},{"key":"B54","doi-asserted-by":"publisher","first-page":"2811789","DOI":"10.1155\/2022\/2811789","article-title":"Targeting oxidative stress and endothelial dysfunction using tanshinone IIA for the treatment of tissue inflammation and fibrosis","volume":"2022","author":"Lu","year":"2022","journal-title":"Oxid Med Cell Longevity"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.778847","article-title":"Recent research progress (2015-2021) and perspectives on the pharmacological effects and mechanisms of tanshinone IIA","volume":"12","author":"Zhong","year":"2021","journal-title":"Front Pharmacol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2021.08.067","article-title":"Tanshinone IIA protects human coronary artery endothelial cells from ferroptosis by activating the NRF2 pathway","volume":"575","author":"He","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.03.033","article-title":"Decoding cell death signals in liver inflammation","volume":"59","author":"Brenner","year":"2013","journal-title":"J Hepatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"a000034","DOI":"10.1101\/cshperspect.a000034","article-title":"The NF-kappaB family of transcription factors and its regulation","volume":"1","author":"Oeckinghaus","year":"2009","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-022-00910-2","article-title":"TNF in the liver: targeting a central player in inflammation","volume":"44","author":"Tiegs","year":"2022","journal-title":"Semin immunopathol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2010.183","article-title":"NF-\u03baB and STAT3 - key players in liver inflammation and cancer","volume":"21","author":"He","year":"2011","journal-title":"Cell Res"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1369\/0022155415627681","article-title":"TGF-\u03b2\/SMAD pathway and its regulation in hepatic fibrosis","volume":"64","author":"Xu","year":"2016","journal-title":"J Histochem Cytochem"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15688","article-title":"Danshen (Salvia miltiorrhiza) restricts MD2\/TLR4-MyD88 complex formation and signalling in acute myocardial infarction-induced heart failure","volume":"24","author":"Wang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e3004","DOI":"10.1038\/cddis.2017.389","article-title":"Total tanshinones exhibits anti-inflammatory effects through blocking TLR4 dimerization via the MyD88 pathway","volume":"8","author":"Gao","year":"2017","journal-title":"Cell Death Dis"},{"key":"B64","doi-asserted-by":"publisher","first-page":"111353","DOI":"10.1016\/j.biopha.2021.111353","article-title":"And tanshinone IIA\/B attenuate LPS-induced mastitis via regulating the NF-\u03baB","volume":"137","author":"Yang","year":"2021","journal-title":"BioMed Pharmacother"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00322","article-title":"Hepatic macrophages in liver injury","volume":"11","author":"Shan","year":"2020","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/liv.14091","article-title":"Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms","volume":"39","author":"Dar","year":"2019","journal-title":"Liver Int"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.2741\/e461","article-title":"Tanshinone IIA pretreatment attenuates hepatic ischemia-reperfusion","volume":"4","author":"Qi","year":"2012","journal-title":"Front biosci. (Elite edition)"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.03.022","article-title":"Pre-conditioning with tanshinone IIA attenuates the ischemia\/reperfusion injury caused by liver grafts via regulation of HMGB1 in rat kupffer cells","volume":"89","author":"Li","year":"2017","journal-title":"BioMed Pharmacother"},{"key":"B69","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1691\/ph.2018.7509","article-title":"Tanshinone IIA activates autophagy to reduce liver ischemia-reperfusion injury by MEK\/ERK\/mTOR pathway","volume":"73","author":"Wang","year":"2018","journal-title":"Die Pharmazie"},{"key":"B70","doi-asserted-by":"publisher","first-page":"108676","DOI":"10.1016\/j.biopha.2019.108676","article-title":"Preventive and therapeutic role of tanshinone II A in hepatology","volume":"112","author":"Shi","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B71","doi-asserted-by":"publisher","first-page":"S417","DOI":"10.33549\/physiolres.933506","article-title":"In vitro and in vivo experimental hepatotoxic models in liver research: applications to the assessment of potential hepatoprotective drugs","volume":"65","author":"Farghali","year":"2016","journal-title":"Physiol Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2009.08.007","article-title":"Preventive effects of a purified extract isolated from salvia miltiorrhiza enriched with tanshinone I, tanshinone IIA and cryptotanshinone on hepatocyte injury in vitro and in vivo","volume":"47","author":"Park","year":"2009","journal-title":"Food Chem Toxicol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2016.02.022","article-title":"Tanshinone IIA protects against acetaminophen-induced hepatotoxicity via activating the Nrf2 pathway","volume":"23","author":"Wang","year":"2016","journal-title":"Phytomedicine"},{"key":"B74","article-title":"[Tanshinone IIA protects against triptolide-induced liver injury via Nrf2\/ARE activation]","volume":"48","author":"Guan","year":"2013","journal-title":"Yao xue xue bao = Acta Pharm Sin"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3109\/08923970903120997","article-title":"Tanshinone IIA protects against immune-mediated liver injury through activation of T-cell subsets and regulation of cytokines","volume":"32","author":"Qin","year":"2010","journal-title":"Immunopharmacol immunotoxicol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.19540\/j.cnki.cjcmm.20190305.002","article-title":"[Mechanisms of tanshinone II_A in reducing 4-HNE-induced hepatocyte damage by activating PPAR\u03b1]","volume":"44","author":"Qian","year":"2019","journal-title":"Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China J Chin mater Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3109\/13880209.2014.889720","article-title":"Salvia miltiorrhiza compounds protect the liver from acute injury by regulation of p38 and NF\u03baB signaling in kupffer cells","volume":"52","author":"Yue","year":"2014","journal-title":"Pharm Biol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2005.01221.x","article-title":"Selective elimination of hepatic natural killer T cells with concanavalin a improves liver regeneration in mice","volume":"26","author":"Huang","year":"2006","journal-title":"Liver int: Off J Int Assoc Study Liver"},{"key":"B79","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/08830180802432178","article-title":"Hepatitis c virus (HCV): a review of immunological aspects","volume":"27","author":"Irshad","year":"2008","journal-title":"Int Rev Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"4097398","DOI":"10.1155\/2016\/4097398","article-title":"Prevention and therapeutic effects and mechanisms of tanshinone IIA sodium sulfonate on acute liver injury mice model","volume":"2016","author":"Lu","year":"2016","journal-title":"Evidence-Based complement Altern med.: eCAM"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.909996","article-title":"Sodium tanshinone IIA sulfonate improves hemodynamic parameters, cytokine release, and multi-organ damage in endotoxemia rabbits","volume":"24","author":"Ma","year":"2018","journal-title":"Med Sci monitor: Int Med J Exp Clin Res"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-008-9206-3","article-title":"Sodium tanshinone IIA sulfonate protects mice from ConA-induced hepatitis via inhibiting NF-kappaB and IFN-gamma\/STAT1 pathways","volume":"28","author":"Xu","year":"2008","journal-title":"J Clin Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i48.10512","article-title":"Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets","volume":"22","author":"Zhang","year":"2016","journal-title":"World J Gastroenterol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5152\/tjg.2018.17330","article-title":"Liver fibrosis","volume":"29","author":"Ayd\u0131n","year":"2018","journal-title":"Turkish J Gastroenterol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s11655-021-3293-x","article-title":"Active components formulation developed from fuzheng huayu recipe for anti-liver fibrosis","volume":"28","author":"Sun","year":"2022","journal-title":"Chin J Integr Med"},{"key":"B86","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Advanced Drug del Rev"},{"key":"B87","doi-asserted-by":"publisher","first-page":"734987","DOI":"10.1155\/2012\/734987","article-title":"Explore the molecular mechanism of apoptosis induced by tanshinone IIA on activated rat hepatic stellate cells","volume":"2012","author":"Pan","year":"2012","journal-title":"Evidence-Based complement Altern med.: eCAM"},{"key":"B88","article-title":"[Effect of tanshinone IIA on CCl4-induced liver fibrosis in rats]","volume":"25","author":"Liu","year":"2002","journal-title":"Zhong yao cai = Zhongyaocai = J Chin med mater"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2009.00465.x","article-title":"Tanshinone II a induces apoptosis and s phase cell cycle arrest in activated rat hepatic stellate cells","volume":"106","author":"Che","year":"2010","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"B90","article-title":"[Effect of tanshinone II on hepatic fibrosis in mice]","volume":"29","author":"Sun","year":"2009","journal-title":"Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chin J integr tradit Western Med"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3390\/molecules24020338","article-title":"Active compounds derived from fuzheng huayu formula protect hepatic parenchymal cells from apoptosis based on network pharmacology and transcriptomic analysis","volume":"24","author":"Wu","year":"2019","journal-title":"Molecules"},{"key":"B92","doi-asserted-by":"publisher","first-page":"e103229","DOI":"10.1371\/journal.pone.0103229","article-title":"Inhibitory effect of tanshinone IIA on rat hepatic stellate cells","volume":"9","author":"Liu","year":"2014","journal-title":"PloS One"},{"key":"B93","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-pathmechdis-012419-032824","article-title":"Liver progenitors and adult cell plasticity in hepatic injury and repair: Knowns and unknowns","volume":"15","author":"Ko","year":"2020","journal-title":"Annu Rev Pathol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13377","article-title":"The diversity and plasticity of adult hepatic progenitor cells and their niche","volume":"37","author":"Chen","year":"2017","journal-title":"Liver Int"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2015.4696","article-title":"Tanshinone IIA promotes the proliferation of WB-F344 hepatic oval cells via wnt\/\u03b2-catenin signaling","volume":"13","author":"Ze","year":"2016","journal-title":"Mol Med Rep"},{"key":"B96","doi-asserted-by":"publisher","first-page":"110815","DOI":"10.1016\/j.biopha.2020.110815","article-title":"Tanshinone IIA exerts therapeutic effects by acting on endogenous stem cells in rats with liver cirrhosis","volume":"132","author":"Yang","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B97","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/b.apha.2015.04.003","article-title":"Bile acid metabolism and signaling in cholestasis, inflammation, and cancer","volume":"74","author":"Li","year":"2015","journal-title":"Adv Pharmacol (San Diego Calif.)"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-14541-4_5","article-title":"The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation","volume":"201","author":"Stieger","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1177\/0960327120979030","article-title":"Tanshinone II A may alleviate rifampin-induced cholestasis by regulating the expression and function of NTCP","volume":"40","author":"Yang","year":"2021","journal-title":"Hum Exp Toxicol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2015.01.047","article-title":"Tanshinone IIA exerts protective effects in a LCA-induced cholestatic liver model associated with participation of pregnane X receptor","volume":"164","author":"Zhang","year":"2015","journal-title":"J ethnopharmacol"},{"key":"B101","article-title":"[Clinical efficiency of tanshinone IIA-sulfonate in treatment of liver fibrosis of advanced schistosomiasis]","volume":"25","author":"Niu","year":"2013","journal-title":"Zhongguo xue xi chong bing fang zhi za zhi = Chin J schistosomiasis control"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.18-3-245","article-title":"Non-alcoholic fatty liver disease","volume":"18","author":"Maurice","year":"2018","journal-title":"Clin Med (London England)"},{"key":"B103","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cld.2017.08.007","article-title":"Pathophysiology of nonalcoholic fatty liver Disease\/Nonalcoholic steatohepatitis","volume":"22","author":"Manne","year":"2018","journal-title":"Clinics liver Dis"},{"key":"B104","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/TP.0000000000002480","article-title":"Nonalcoholic fatty liver disease: Basic pathogenetic mechanisms in the progression from NAFLD to NASH","volume":"103","author":"Pierantonelli","year":"2019","journal-title":"Transplantation"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1177\/0300060519859750","article-title":"Tanshinone IIA ameliorates non-alcoholic fatty liver disease through targeting peroxisome proliferator-activated receptor gamma and toll-like receptor 4","volume":"47","author":"Huang","year":"2019","journal-title":"J Int Med Res"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.5162","article-title":"Effect of tanshinone IIA on oxidative stress and apoptosis in a rat model of fatty liver","volume":"14","author":"Yang","year":"2017","journal-title":"Exp Ther Med"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3736\/jintegrmed2013034","article-title":"Bioactivity of five components of Chinese herbal formula jiangzhi granules against hepatocellular steatosis","volume":"11","author":"Song","year":"2013","journal-title":"J Integr Med"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18030620","article-title":"A biomedical investigation of the hepatoprotective effect of radix salviae miltiorrhizae and network pharmacology-based prediction of the active compounds and molecular targets","volume":"18","author":"Hong","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B109","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.biopha.2018.12.019","article-title":"Sodium tanshinone IIA sulfonate ameliorates hepatic steatosis by inhibiting lipogenesis and inflammation","volume":"111","author":"Li","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12510","article-title":"Tanshinone IIA reduces palmitate-induced apoptosis via inhibition of endoplasmic reticulum stress in HepG2 liver cells","volume":"34","author":"Wang","year":"2020","journal-title":"Fundam Clin Pharmacol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-001-1209-2","article-title":"Effects of tanshinone IIA on the hepatotoxicity and gene expression involved in alcoholic liver disease","volume":"31","author":"Yin","year":"2008","journal-title":"Arch pharmacal Res"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet (London England)"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American college of gastroenterology, and the American gastroenterological association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatol (Baltimore Md.)"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2014.07.008","article-title":"Non-alcoholic fatty liver disease, obesity and the metabolic syndrome","volume":"28","author":"Dietrich","year":"2014","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1159\/000329800","article-title":"Obesity and fatty liver are \u2018grease\u2019 for the machinery of hepatic fibrosis","volume":"29","author":"Bosserhoff","year":"2011","journal-title":"Digest Dis (Basel Switzerland)"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3390\/nu5051544","article-title":"Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease","volume":"5","author":"Gaggini","year":"2013","journal-title":"Nutrients"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2015.05.041","article-title":"Dan-Qi prescription ameliorates insulin resistance through overall corrective regulation of glucose and fat metabolism","volume":"172","author":"Xie","year":"2015","journal-title":"J ethnopharmacol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2012.12.066","article-title":"Tanshinone IIA improves endoplasmic reticulum stress-induced insulin resistance through AMP-activated protein kinase","volume":"430","author":"Hwang","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2018.6674","article-title":"Tanshinone IIA improves diabetes mellitus via the NF-\u03baB-induced AMPK signal pathway","volume":"16","author":"Yuan","year":"2018","journal-title":"Exp Ther Med"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.18632\/aging.100934","article-title":"Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies","volume":"8","author":"Pistritto","year":"2016","journal-title":"Aging"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.7314\/APJCP.2015.16.6.2129","article-title":"Molecular mechanisms of apoptosis and roles in cancer development and treatment","volume":"16","author":"Goldar","year":"2015","journal-title":"Asian Pac J Cancer prev: APJCP"},{"key":"B123","article-title":"CDK6 (PLSTIRE) and CDK4 (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1","volume":"9","author":"Bates","year":"1994","journal-title":"Oncogene"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1101\/gad.7.3.331","article-title":"Direct binding of cyclin d to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin d-dependent kinase CDK4","volume":"7","author":"Kato","year":"1993","journal-title":"Genes Dev"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.18632\/genesandcancer.120","article-title":"Dual function of MDM2 and MDMX toward the tumor suppressors p53 and RB","volume":"7","author":"Hern\u00e1ndez-Monge","year":"2016","journal-title":"Genes Cancer"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.24553","article-title":"Tanshinone IIA inhibits breast cancer stem cells growth in vitro and in vivo through attenuation of IL-6\/STAT3\/NF-kB signaling pathways","volume":"114","author":"Lin","year":"2013","journal-title":"J Cell Biochem"},{"key":"B127","doi-asserted-by":"publisher","first-page":"23681","DOI":"10.1038\/s41598-021-03166-2","article-title":"Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA\/PLK1 pathway","volume":"11","author":"Li","year":"2021","journal-title":"Sci Rep"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.11.037","article-title":"Emerging biological principles of metastasis","volume":"168","author":"Lambert","year":"2017","journal-title":"Cell"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1042\/BST20160387","article-title":"Cancer-associated fibroblasts modulate growth factor signaling and extracellular matrix remodeling to regulate tumor metastasis","volume":"45","author":"Erdogan","year":"2017","journal-title":"Biochem Soc Trans"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-018-0656-6","article-title":"Epithelial-to-mesenchymal transition in cancer: complexity and opportunities","volume":"12","author":"Zhang","year":"2018","journal-title":"Front Med"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102420","article-title":"Tanshinone IIA mediates SMAD7-YAP interaction to inhibit liver cancer growth by inactivating the transforming growth factor beta signaling pathway","volume":"11","author":"Ma","year":"2019","journal-title":"Aging"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.1007-3418.2010.06.011","article-title":"[Effects of e-selectin and their ligands on the adhesive metastasis of hepatocellular carcinoma]","volume":"18","author":"Qian","year":"2010","journal-title":"Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chin J Hepatol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S161534","article-title":"Synergistic antitumor effects of tanshinone IIA and sorafenib or its derivative SC-1 in hepatocellular carcinoma cells","volume":"11","author":"Chiu","year":"2018","journal-title":"OncoTargets Ther"},{"key":"B135","article-title":"Tanshinone II improves distribution and anti-tumor efficacy of pegylated liposomal doxorubicin via normalizing the structure and function of tumor vasculature in hepa1-6 hepatoma mice model","volume":"38","author":"Zhang","year":"2018","journal-title":"J tradit Chin Med = Chung i tsa chih ying wen pan"},{"key":"B136","article-title":"[Synergistic antitumor effects of tanshinone II a in combination with cisplatin via apoptosis in the prostate cancer cells]","volume":"48","author":"Hou","year":"2013","journal-title":"Yao xue xue bao = Acta Pharm Sin"},{"key":"B137","doi-asserted-by":"publisher","first-page":"805639","DOI":"10.1155\/2013\/805639","article-title":"Apoptosis induced by tanshinone IIA and cryptotanshinone is mediated by distinct JAK\/STAT3\/5 and SHP1\/2 signaling in chronic myeloid leukemia K562 cells","volume":"2013","author":"Jung","year":"2013","journal-title":"Evidence-Based complement Altern med.: eCAM"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2011.441","article-title":"Tanshinone IIA potentiates the efficacy of 5-FU in Colo205 colon cancer cells in vivo through downregulation of p-gp and LC3-II","volume":"3","author":"Su","year":"2012","journal-title":"Exp Ther Med"},{"key":"B139","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/03602530902843483","article-title":"Polymorphism of human cytochrome P450 enzymes and its clinical impact","volume":"41","author":"Zhou","year":"2009","journal-title":"Drug Metab Rev"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3109\/00498254.2015.1027971","article-title":"Decreased elimination clearance of midazolam by doxorubicin through reductions in the metabolic activity of hepatic CYP3A in rats","volume":"45","author":"Nagai","year":"2015","journal-title":"Xenobiotica; fate foreign compd Biol Syst"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.21873\/cgp.20054","article-title":"CYP3A4 gene is a novel biomarker for predicting a poor prognosis in hepatocellular carcinoma","volume":"14","author":"Ashida","year":"2017","journal-title":"Cancer Genomics Proteomics"},{"key":"B142","first-page":"1","article-title":"Cancer multidrug resistance (MDR): a major impediment to effective chemotherapy","volume":"9","author":"Ullah","year":"2008","journal-title":"Asian Pac J Cancer prev: APJCP"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.6353","article-title":"Combination of tanshinone IIA and doxorubicin possesses synergism and attenuation effects on doxorubicin in the treatment of breast cancer","volume":"33","author":"Li","year":"2019","journal-title":"Phytother res: PTR"},{"key":"B144","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting STAT3 in cancer immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol Cancer"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.760971","article-title":"IL-6\/STAT3 is a promising therapeutic target for hepatocellular carcinoma","volume":"11","author":"Xu","year":"2021","journal-title":"Front Oncol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1634\/theoncologist.2010-S4-05","article-title":"The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective","volume":"15","author":"Venook","year":"2010","journal-title":"Oncologist"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1159\/000343852","article-title":"From cirrhosis to hepatocellular carcinoma: new molecular insights on inflammation and cellular senescence","volume":"2","author":"Ramakrishna","year":"2013","journal-title":"Liver Cancer"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55090526","article-title":"Hepatocellular carcinoma: Molecular mechanisms and targeted therapies","volume":"55","author":"Alqahtani","year":"2019","journal-title":"Med (Kaunas)"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i19.2279","article-title":"Mechanisms of hepatocellular carcinoma progression","volume":"25","author":"Ogunwobi","year":"2019","journal-title":"World J Gastroenterol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.JCRT_862_16","article-title":"Oxidative stress and its role in cancer","volume":"17","author":"Jelic","year":"2021","journal-title":"J Cancer Res Ther"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.2174\/1381612825666190215121712","article-title":"Oxidative stress and cancer","volume":"24","author":"Klaunig","year":"2018","journal-title":"Curr Pharm Des"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.1687","article-title":"Identification of novel therapeutic targets in the PI3K\/AKT\/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing","volume":"5","author":"Janku","year":"2014","journal-title":"Oncotarget"},{"key":"B153","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3892\/etm.2020.8454","article-title":"ERK\/MAPK signalling pathway and tumorigenesis","volume":"19","author":"Guo","year":"2020","journal-title":"Exp Ther Med"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.159046","article-title":"ERK1\/2 phosphorylate raptor to promote ras-dependent activation of mTOR complex 1 (mTORC1)","volume":"286","author":"Carriere","year":"2011","journal-title":"J Biol Chem"},{"key":"B155","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1208\/s12249-021-01973-4","article-title":"Galactose-modified PH-sensitive niosomes for controlled release and hepatocellular carcinoma target delivery of tanshinone IIA","volume":"22","author":"Hu","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x2020e10685","article-title":"Tanshinone I inhibited growth of human chronic myeloid leukemia cells via JNK\/ERK mediated apoptotic pathways","volume":"54","author":"Sun","year":"2021","journal-title":"Braz J Med Biol Res = Rev Bras pesquisas med e biol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6670","article-title":"Tanshinone IIA can inhibit MiaPaCa-2 human pancreatic cancer cells by dual blockade of the Ras\/Raf\/MEK\/ERK and PI3K\/AKT\/mTOR pathways","volume":"40","author":"Su","year":"2018","journal-title":"Oncol Rep"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i15.1964","article-title":"Mechanisms of hepatocellular carcinoma and challenges and opportunities for molecular targeted therapy","volume":"7","author":"Chen","year":"2015","journal-title":"World J Hepatol"},{"key":"B159","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000327562","article-title":"Signaling pathway and molecular-targeted therapy for hepatocellular carcinoma","volume":"29","author":"Kudo","year":"2011","journal-title":"Digest Dis (Basel Switzerland)"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1002\/mc.23045","article-title":"Antitumor activity of potent pyruvate dehydrogenase kinase 4 inhibitors from plants in pancreatic cancer","volume":"58","author":"Tambe","year":"2019","journal-title":"Mol carcinog"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2008.07.078","article-title":"Oncogenic MAPK signaling stimulates mTORC1 activity by promoting RSK-mediated raptor phosphorylation","volume":"18","author":"Carri\u00e8re","year":"2008","journal-title":"Curr biol: CB"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00193","article-title":"The anticancer properties of tanshinones and the pharmacological effects of their active ingredients","volume":"11","author":"Fu","year":"2020","journal-title":"Front Pharmacol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2022.01.027","article-title":"Tuberous sclerosis complex gene products, tuberin and hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward rheb","volume":"32","author":"Tee","year":"2022","journal-title":"Curr biol: CB"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01264","article-title":"Uncovering the mechanisms of cryptotanshinone as a therapeutic agent against hepatocellular carcinoma","volume":"11","author":"Luo","year":"2020","journal-title":"Front Pharmacol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40360-020-00410-9","article-title":"Inhibition of PI3K\/AKT molecular pathway mediated by membrane estrogen receptor GPER accounts for cryptotanshinone induced antiproliferative effect on breast cancer SKBR-3 cells","volume":"21","author":"Shi","year":"2020","journal-title":"BMC Pharmacol Toxicol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrc3860","article-title":"PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting","volume":"15","author":"Thorpe","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2011.03.006","article-title":"The ras-ERK and PI3K-mTOR pathways: cross-talk and compensation","volume":"36","author":"Mendoza","year":"2011","journal-title":"Trends Biochem Sci"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1111\/jphp.12961","article-title":"Tanshinone IIA effects on ovarian cancer cell line","volume":"70","author":"Li","year":"2018","journal-title":"J Pharm Pharmacol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2016.03.031","article-title":"Tanshinone II A inhibits human esophageal cancer cell growth through miR-122-mediated PKM2 down-regulation","volume":"598","author":"Zhang","year":"2016","journal-title":"Arch Biochem biophys"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1016\/j.fsi.2018.02.046","article-title":"Serum immune responses in common carp (Cyprinus carpio l.) to paraquat exposure: The traditional parameters and circulating microRNAs","volume":"76","author":"Ma","year":"2018","journal-title":"Fish shellfish Immunol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.3390\/ijms151018422","article-title":"Characterization of paraquat-induced miRNA profiling response in hNPCs undergoing proliferation","volume":"15","author":"Huang","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.5620\/eht.e2018014","article-title":"A review of current studies on cellular and molecular mechanisms underlying pulmonary fibrosis induced by chemicals","volume":"33","author":"Kim","year":"2018","journal-title":"Environ Health Toxicol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1242\/jcs.099200","article-title":"MicroRNAs and their roles in aging","volume":"125","author":"Smith-Vikos","year":"2012","journal-title":"J Cell Sci"},{"key":"B174","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1186\/s12885-017-3816-1","article-title":"MicroRNA profile in HBV-induced infection and hepatocellular carcinoma","volume":"17","author":"Wang","year":"2017","journal-title":"BMC Cancer"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.3892\/or.2016.5299","article-title":"Gigantol attenuates the proliferation of human liver cancer HepG2 cells through the PI3K\/Akt\/NF-\u03baB signaling pathway","volume":"37","author":"Chen","year":"2017","journal-title":"Oncol Rep"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910774","article-title":"Anti-hepatocellular carcinoma biomolecules: Molecular targets insights","volume":"22","author":"Juaid","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.2174\/0929867328666211108110025","article-title":"Pharmacology, total synthesis, and progress in structure-modifications","volume":"29","author":"Huang","year":"2022","journal-title":"Curr Med Chem"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1080\/14786419.2016.1138302","article-title":"Design, synthesis, and antimicrobial activities of new tanshinone IIA esters","volume":"30","author":"Zeng","year":"2016","journal-title":"Natural prod Res"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2009.08.010","article-title":"Tanshinone II a attenuates inflammatory responses of rats with myocardial infarction by reducing MCP-1 expression","volume":"17","author":"Ren","year":"2010","journal-title":"Phytomedicine"},{"key":"B180","article-title":"Progress in research on anticancer effect of tanshinone II A and its mechanisms both in vivo and in vitro","volume":"26","author":"Lu","year":"2014","journal-title":"Cancer Res Clin"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.16333\/j.1001-6880.2009.03.007","article-title":"Study on the sodium tanshinone II a sulfonate and its synthesis technics","volume":"21","author":"Yao","year":"2009","journal-title":"Natural Product Research and Development"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.13840\/j.cnki.cn21-1457\/tq.2014.06.028","article-title":"Preparation of tanshinone II a derivative phenanthro [1,2-b]furan-10,11-methylene-dioxy-6,7,8,9-tetrahydro-1,6,6-trimethyl","volume":"43","author":"Pan","year":"2014","journal-title":"Contemporary Chemical Industry"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1021\/jm800219f","article-title":"The many roles for fluorine in medicinal chemistry","volume":"51","author":"Hagmann","year":"2008","journal-title":"J med Chem"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S266911","article-title":"Pharmacological activity and mechanism of tanshinone IIA in related diseases","volume":"14","author":"Guo","year":"2020","journal-title":"Drug design Dev Ther"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22040660","article-title":"Evaluation of tanshinone IIA developmental toxicity in zebrafish embryos","volume":"22","author":"Wang","year":"2017","journal-title":"Molecules"},{"key":"B186","doi-asserted-by":"publisher","first-page":"110599","DOI":"10.1016\/j.biopha.2020.110599","article-title":"Pharmacological basis of tanshinone and new insights into tanshinone as a multitarget natural product for multifaceted diseases","volume":"130","author":"Li","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B187","doi-asserted-by":"publisher","first-page":"7514046","DOI":"10.1155\/2019\/7514046","article-title":"Therapeutic effect of tanshinone IIA on liver fibrosis and the possible mechanism: A preclinical meta-analysis","volume":"2019","author":"Ying","year":"2019","journal-title":"Evidence-Based complement Altern med.: eCAM"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0300-y","article-title":"Immunomodulation by anticancer cell cycle inhibitors","volume":"20","author":"Petroni","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B189","doi-asserted-by":"publisher","first-page":"109362","DOI":"10.1016\/j.biopha.2019.109362","article-title":"Sodium tanshinone IIA sulfonate: A review of pharmacological activity and pharmacokinetics","volume":"118","author":"Zhou","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B190","article-title":"[Study on the pharmacokinetics of tashinone II(A) -loaded polylactic acid nanoparticles in rabbit]","volume":"34","author":"Wang","year":"2011","journal-title":"Zhong yao cai = Zhongyaocai = J Chin med mater"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1071415\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T16:13:41Z","timestamp":1675181621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1071415\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,31]]},"references-count":190,"alternative-id":["10.3389\/fonc.2023.1071415"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1071415","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,31]]},"article-number":"1071415"}}